URI
53
3
AN
50
7
NFLX
59
2
CAG
37
3
BAX
44
2
RRC
46
-2
OKE
70
3
GT
43
2
ADBE
56
-13
DE
50
2
VRTX
62
5
FOX
33
3
TEL
60
3
HOG
38
5
AIV
65
-2
SYF
64
4
HPE
46
2
MAC
62
4
CA
48
4
CMS
70
2
URI
53
3
AN
50
7
NFLX
59
2
CAG
37
3
BAX
44
2
RRC
46
-2
OKE
70
3
GT
43
2
ADBE
56
-13
DE
50
2
VRTX
62
5
FOX
33
3
TEL
60
3
HOG
38
5
AIV
65
-2
SYF
64
4
HPE
46
2
MAC
62
4
CA
48
4
CMS
70
2
Financhill
Back

Bio-Path Holdings Quote, Financials, Valuation and Earnings

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29

BPTH
Bio-Path Holdings

Last Price:
1.03
Seasonality Move:
9.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Hint at where the next big move in the market will be this month

Spot the next big move with this free book from a hedge fund manager

Bio-Path Holdings Price Quote

$1.03
+0.01 (+0.98%)
(Updated: September 16, 2024 at 3:10 PM ET)

Bio-Path Holdings Key Stats

Sell
29
Bio-Path Holdings (BPTH) is a Sell
Day range:
$0.94 - $1.04
52-week range:
$0.91 - $21.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.02%
Volume:
85.2K
Avg. volume:
615.7K
1-year change:
-87.18%
Market cap:
$2.6M
Revenue:
$0
EPS:
$-16.67

How Much Does Bio-Path Holdings Make?

Data Unavailable

Is Bio-Path Holdings Growing As A Company?

Data Unavailable

Bio-Path Holdings Stock Price Performance

What Is Bio-Path Holdings 52-Week High & Low?

Bio-Path Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bio-Path Holdings?

  • How Much Debt Does Bio-Path Holdings Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Bio-Path Holdings Have?
    Cash and short term investments quarterly total is $4M
  • What Is Bio-Path Holdings’s Book Value Per Share?
    Book value per share is 0.57

Is Bio-Path Holdings Cash Flow Positive?

  • What Is BPTH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.9M
  • What Is Bio-Path Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $9.4M
  • What Is Bio-Path Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Bio-Path Holdings Return On Invested Capital

Data Unavailable

Bio-Path Holdings Earnings Date & Stock Price

Bio-Path Holdings Competitors

  • Who Are Bio-Path Holdings's Competitors?
    Below is a list of companies who compete with Bio-Path Holdings or are related in some way:
    • Aadi Bioscience Inc (AADI)
    • Actinium Pharmaceuticals Inc (ATNM)
    • Bristol-Myers Squibb Co (BMY)
    • NovaBay Pharmaceuticals Inc (NBY)
    • SELLAS Life Sciences Group Inc (SLS)

Bio-Path Holdings Dividend Yield

Bio-Path Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 24.68%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 20.00
Upside from Last Price: 1860.78%

Major Shareholders

  • How many BPTH shares are owned by institutional investors?
    209.7K BPTH shares are owned by institutional investors
  • How many BPTH shares are owned by insiders?
    0 BPTH shares are owned by insiders